Released on: September 6, 2007, 9:56 am

Press Release Author: Plexus Ventures LLC

Industry: Pharmaceuticals

Press Release Summary: Plexus Ventures is pleased to announce its appointment by
GlaxoSmithKline Consumer Healthcare to augment the company\'s internal resources by
providing additional business development services.

Press Release Body: Philadelphia, Pennsylvania, September 6, 2007 - Plexus Ventures
is pleased to announce its appointment by GlaxoSmithKline Consumer Healthcare to
augment the company\'s internal resources by providing additional business
development services.

Bob Moran, President of Plexus Ventures, commented: \"With 10 seasoned business
development professionals in eight cities worldwide, Plexus Ventures is
well-positioned to help GSK achieve its growth objectives.\"


About Plexus Ventures
Plexus Ventures, founded in 1990, provides strategic advice, business development
and alliance management services to clients in the pharmaceutical, biotechnology and
drug delivery industries worldwide. Plexus Ventures assists its clients in the areas
of in-licensing, out-licensing, acquisitions, divestitures and strategic
partnerships. With offices in Frankfurt, Indianapolis, London, Los Angeles, Milan,
Philadelphia, Tokyo and Warsaw, Plexus Ventures possesses the capabilities to
effectively serve clients in the United States, Europe and Asia. Plexus Ventures is
both well-known and well respected by leading research-based pharmaceutical
companies worldwide. For further information, please consult
http://www.plexusventures.com

About GlaxoSmithKline
GlaxoSmithKline is one of the world\'s leading research-based pharmaceutical and
healthcare companies - is committed to improving the quality of human life by
enabling people to do more, feel better and live longer. For company information,
visit www.gsk.com.

About GlaxoSmithKline Consumer Healthcare
GlaxoSmithKline Consumer Healthcare is one of the world\'s largest over-the-counter
consumer healthcare products companies. Its more than 30 well-known brands include
the leading smoking cessation products, Nicoderm CQ® and Commit® (known as Niquitin®
in Europe and International markets); AlliTM, the new product in the US for weight
loss, many medicine cabinet staples including Panadol®, Abreva®, Aquafresh®,
Sensodyne® and Tums®; and nutritional healthcare products such as Lucozade®,
Horlicks® and Ribena®.

Media Contact: Mary Alice Strong
maryalice_strong@plexusventures.com
310-315-7106


Web Site: http://www.plexusventures.com

Contact Details: Mary Alice Strong
Plexus Ventures LLC
1223 Wilshire Blvd #941
Santa Monica, CA 90403
310-315-7106
maryalice_strong@plexusventures.com